BIOMAT Database Logo BIOMAT Database Logo

Recurrence of secukinumab-induced eczematous eruptions after guselkumab treatment for pustular psoriasis. 2021

Fumi Miyagawa, and Keiko Fukuda, and Asuka Mori, and Kohei Ogawa, and Hideo Asada
Department of Dermatology, Nara Medical University School of Medicine, Kashihara, Japan.

UI MeSH Term Description Entries
D011565 Psoriasis A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis. Palmoplantaris Pustulosis,Pustular Psoriasis of Palms and Soles,Pustulosis Palmaris et Plantaris,Pustulosis of Palms and Soles,Psoriases
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012720 Severity of Illness Index Levels within a diagnostic group which are established by various measurement criteria applied to the seriousness of a patient's disorder. Illness Index Severities,Illness Index Severity
D012872 Skin Diseases, Vesiculobullous Skin diseases characterized by local or general distributions of blisters. They are classified according to the site and mode of blister formation. Lesions can appear spontaneously or be precipitated by infection, trauma, or sunlight. Etiologies include immunologic and genetic factors. (From Scientific American Medicine, 1990) Bullous Skin Diseases,Pustular Dermatosis, Subcorneal,Skin Diseases, Bullous,Skin Diseases, Vesicular,Sneddon-Wilkinson Disease,Subcorneal Pustular Dermatosis,Vesicular Skin Diseases,Vesiculobullous Skin Diseases,Bullous Dermatoses,Vesiculobullous Dermatoses,Bullous Skin Disease,Dermatoses, Bullous,Dermatoses, Subcorneal Pustular,Dermatoses, Vesiculobullous,Dermatosis, Subcorneal Pustular,Pustular Dermatoses, Subcorneal,Skin Disease, Bullous,Skin Disease, Vesicular,Skin Disease, Vesiculobullous,Sneddon Wilkinson Disease,Subcorneal Pustular Dermatoses,Vesicular Skin Disease,Vesiculobullous Skin Disease
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes
D061067 Antibodies, Monoclonal, Humanized Antibodies from non-human species whose protein sequences have been modified to make them nearly identical with human antibodies. If the constant region and part of the variable region are replaced, they are called humanized. If only the constant region is modified they are called chimeric. INN names for humanized antibodies end in -zumab. Antibodies, Humanized,Humanized Antibodies

Related Publications

Fumi Miyagawa, and Keiko Fukuda, and Asuka Mori, and Kohei Ogawa, and Hideo Asada
Eczematous eruption after guselkumab treatment for psoriasis.
November 2019, JAAD case reports,
Fumi Miyagawa, and Keiko Fukuda, and Asuka Mori, and Kohei Ogawa, and Hideo Asada
Secukinumab-induced paradoxical pustular psoriasis.
January 2019, Clinical and experimental dermatology,
Fumi Miyagawa, and Keiko Fukuda, and Asuka Mori, and Kohei Ogawa, and Hideo Asada
Treatment of recurrent pustular eruptions ("pustular psoriasis") with cortisone.
August 1951, A.M.A. archives of dermatology and syphilology,
Fumi Miyagawa, and Keiko Fukuda, and Asuka Mori, and Kohei Ogawa, and Hideo Asada
Eczematous and pustular eruptions of the hands.
February 1949, Archives of dermatology and syphilology,
Fumi Miyagawa, and Keiko Fukuda, and Asuka Mori, and Kohei Ogawa, and Hideo Asada
Successful secukinumab treatment of generalized pustular psoriasis.
March 2024, Dermatology online journal,
Fumi Miyagawa, and Keiko Fukuda, and Asuka Mori, and Kohei Ogawa, and Hideo Asada
Successful treatment of generalized pustular psoriasis with guselkumab.
December 2024, The Journal of dermatological treatment,
Fumi Miyagawa, and Keiko Fukuda, and Asuka Mori, and Kohei Ogawa, and Hideo Asada
Successful Secukinumab treatment of generalized pustular psoriasis and erythrodermic psoriasis.
September 2017, Journal of the European Academy of Dermatology and Venereology : JEADV,
Fumi Miyagawa, and Keiko Fukuda, and Asuka Mori, and Kohei Ogawa, and Hideo Asada
Secukinumab in Generalized Pustular Psoriasis.
January 2018, Indian dermatology online journal,
Fumi Miyagawa, and Keiko Fukuda, and Asuka Mori, and Kohei Ogawa, and Hideo Asada
Successful secukinumab treatment of recalcitrant juvenile generalized pustular psoriasis.
March 2020, The Journal of dermatology,
Fumi Miyagawa, and Keiko Fukuda, and Asuka Mori, and Kohei Ogawa, and Hideo Asada
Secukinumab for the treatment of generalized pustular psoriasis: A case report.
May 2023, Medicine,
Copied contents to your clipboard!